Loading...
•
Jun 30, 2020
Schrodinger Q2 2020 Earnings Report
Reported a 21% increase in total revenue year-over-year, driven by a 44% increase in software revenue and strategic agreements with Thermo Fisher and Viva Biotech.
Key Takeaways
Schrödinger, Inc. announced financial results for the second quarter ended June 30, 2020, with total revenue of $23.1 million, a 21% increase compared to the second quarter of 2019. The company saw significant growth in its software business and advanced its drug discovery programs.
Total revenue increased by 21% year-over-year, reaching $23.1 million.
Software revenue grew by 44% year-over-year, amounting to $20.9 million.
Gross profit increased by 38% over the second quarter of 2019, reaching $13.6 million.
Net loss was $3.4 million, compared to a loss of $0.5 million in the second quarter of 2019.
Schrodinger
Schrodinger
Schrodinger Revenue by Segment
Revenue by Segment
Software Products and Services Revenue
CapyFin.comDrug Discovery Revenue
CapyFin.comRevenue & Expenses
Visualization of income flow from segment revenue to net income